When assessing baseline characteristics by comparator (Additional file 4: Appendix Table S4C), the proportion of subjects with heart failure, other prior CV events and prior insulin use was higher, and mean eGFR was lower, in the placebo and semaglutide groups than in the other comparator groups, driven by the large patient numbers and high baseline CV risk in the CVOTs
Reasons for GLP-1 discontinuation (e.g., cost, side effects, clinical decision) were not available
Bioavailability: 1 to 2% absorbed passively without intrinsic factor Deficiency: only if GI absorption is intact Dosing: daily, high-dose oral Prescription: no, available OTC At home: yes Get a B12 injection prescription Not sure which format fits your situation
3 Surgical interventions are often used for advanced-stage IDD 4 to address severe neurological symptoms in an effort to restore the height and maintain stability of the intervertebral space